Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susan O'Brien

Showing results (21-30 of 643) with videos related to

Pageof 65
Sort By:
Expert Review of Hematology|October 3, 2013
The frontline treatment of chronic myeloid leukemia in the chronic phase: current clinical decisions and future prospects for treatmentNitin Jain, Susan O'Brien
Cancer|October 24, 2013
Reply to myelosuppression after frontline fludarabine, cyclophosphamide, and rituximab in patients with chronic lymphocytic leukemia: analysis of persistent and new-onset cytopeniaPaolo Strati, Susan O'Brien
JAMA Oncology|October 8, 2020
Minimal Residual Disease in Acute Myeloid LeukemiaDeepa Jeyakumar, Susan O'Brien
Mayo Clinic Proceedings|December 14, 2005
Chronic lymphoid leukemias other than chronic lymphocytic leukemia: diagnosis and treatmentFarhad Ravandi, Susan O'Brien
Cancer Immunology, Immunotherapy : CII|July 19, 2005
Immune defects in patients with chronic lymphocytic leukemiaFarhad Ravandi, Susan O'Brien
Oncology (Williston Park, N.Y.)|February 19, 2013
Richter's transformation in chronic lymphocytic leukemiaPreetesh Jain, Susan O'Brien
Clinical Lymphoma, Myeloma & Leukemia|October 30, 2010
Ofatumumab: a new CD20 monoclonal antibody therapy for B-cell chronic lymphocytic leukemiaSusan O'Brien, Anders Osterborg
Cancer|July 13, 2010
Questions regarding frontline therapy of acute myeloid leukemiaHagop Kantarjian, Susan O'Brien
Current Hematologic Malignancy Reports|March 30, 2013
Novel therapeutic strategies in adult acute lymphoblastic leukemia--a focus on emerging monoclonal antibodiesNaval Daver, Susan O'Brien
Hematology/Oncology Clinics of North America|August 7, 2013
Ibrutinib (PCI-32765) in chronic lymphocytic leukemiaNitin Jain, Susan O'Brien
Pageof 65

Showing results (21-30 of 643) with videos related to

Sort By:
Pageof 65
Expert Review of Hematology|October 3, 2013
The frontline treatment of chronic myeloid leukemia in the chronic phase: current clinical decisions and future prospects for treatmentNitin Jain, Susan O'Brien
Cancer|October 24, 2013
Reply to myelosuppression after frontline fludarabine, cyclophosphamide, and rituximab in patients with chronic lymphocytic leukemia: analysis of persistent and new-onset cytopeniaPaolo Strati, Susan O'Brien
JAMA Oncology|October 8, 2020
Minimal Residual Disease in Acute Myeloid LeukemiaDeepa Jeyakumar, Susan O'Brien
Mayo Clinic Proceedings|December 14, 2005
Chronic lymphoid leukemias other than chronic lymphocytic leukemia: diagnosis and treatmentFarhad Ravandi, Susan O'Brien
Cancer Immunology, Immunotherapy : CII|July 19, 2005
Immune defects in patients with chronic lymphocytic leukemiaFarhad Ravandi, Susan O'Brien
Oncology (Williston Park, N.Y.)|February 19, 2013
Richter's transformation in chronic lymphocytic leukemiaPreetesh Jain, Susan O'Brien
Clinical Lymphoma, Myeloma & Leukemia|October 30, 2010
Ofatumumab: a new CD20 monoclonal antibody therapy for B-cell chronic lymphocytic leukemiaSusan O'Brien, Anders Osterborg
Cancer|July 13, 2010
Questions regarding frontline therapy of acute myeloid leukemiaHagop Kantarjian, Susan O'Brien
Current Hematologic Malignancy Reports|March 30, 2013
Novel therapeutic strategies in adult acute lymphoblastic leukemia--a focus on emerging monoclonal antibodiesNaval Daver, Susan O'Brien
Hematology/Oncology Clinics of North America|August 7, 2013
Ibrutinib (PCI-32765) in chronic lymphocytic leukemiaNitin Jain, Susan O'Brien
Pageof 65